Business & Regulation

New forays into the pharma space and a billion-dollar discovery deal… What’s new in business?

Researchers identify several factors associated with shorter marketing exclusivity periods.

How can small molecule "degraders" help target disease-causing proteins?

The FDA has approved its first biosimilar of 2020: Pfizer’s Nyvepria (pegfilgrastim-apgf).

How is the business of making medicine changing in light of the COVID-19 pandemic?

Sitting Down With... JoyL Silva, General Manager at PfizerCentre.

Sitting Down With… Bobby Sheng, Chairman and CEO of Bora Pharmaceuticals, Taiwan.

How Raman spectroscopy-based technologies enable the pharma industry to streamline analytical workflows.

Sitting Down With... Kelly Chibale, Director, H3D, University of Cape Town, South Africa.

In under two months, the ISCT managed to pull together a gamified virtual conference platform.